Drug news—May 2024A review of new launches, new indications, new dosage forms and Health Canada advisories. Three new indications: Bimzelx, Keytruda and MirenaGet the info you need on the latest updates on new indications for existing drugs as part of our drug news roundup for May. Patients who end up in ER for severe dependence on alcohol need medications: doctors Are the typical methods used to deal with withdrawal good enough? How much does a patient weigh? In emergency medicine, finding the answer isn't always so simple A new review examines best way to get the most accurate estimation of a patient’s weight to optimize dosage calculations and more. Mail-order mifepristone effective, acceptable and feasible: study The study found that more than 90% of participants were satisfied with medication abortion by mail. Two new dosage forms: Eylea HD and pms-Methotrexate Injection Get the info you need on the latest updates to dosage forms as part of our drug news roundup for May. NEW PRODUCT: Opdualag for unresectable or metastatic melanoma Get the info you need on this new product, part of our drug news roundup for May. NEW PRODUCT: Nypozi for several neutropenia-related indications Get the info you need on this new product, part of our drug news roundup for May. Misleading monographs? These doctors say estrogen creams are safe and should be viewed that way ‘They’re not just safe, but there’s harm in not using these creams. Women can die from not using them.’ NEW PRODUCT: Epkinly for treatment of relapsed or refractory diffuse large B-cell lymphoma Get the info you need on this new product, part of our drug news roundup for May. First Previous 12 13 14 15 16 Next Last